We describe a highly aggressive squamous cell carcinoma that presents in a dermatome pattern shortly following shingles and review the literature on herpetiform lesions.

AIM To investigate the sensitivity of various laboratory approaches in the diagnosis of herpes zoster from patient serum. METHODS Paired sera from 53 consecutive adult patients with acute herpes zoster were tested for the presence of varicella-zoster virus (VZV) antibodies. All acute sera were tested subsequently by real-time polymerase chain reaction (PCR) for the presence of VZV DNA. In add...

July 2005 | Volume 2 | Issue 7 | e238 | e242 Postherpetic neuralgia (PHN) is a chronically painful condition that is a complication of shingles (acute herpes zoster), a recurrence of the varicellazoster virus, which initially causes chickenpox. Although shingles usually resolves within a month, some people continue to feel the pain of PHN long after the rash and blisters heal, because of nerve ...

This work aims at the full recovery of efficiency losses induced by shingling double-side poly-Si/SiO x passivated contacts crystalline silicon solar cells. It focuses on thermally-activated Aluminium Oxide (AlO ) layers elaborated thermal Atomic Layer Deposition (ALD) to passivate edges shingled cells cut using innovative “45° tilt squaring approach”. The whole procedure featuring high-tempera...

July 2005 | Volume 2 | Issue 7 | e238 | e242 Postherpetic neuralgia (PHN) is a chronically painful condition that is a complication of shingles (acute herpes zoster), a recurrence of the varicellazoster virus, which initially causes chickenpox. Although shingles usually resolves within a month, some people continue to feel the pain of PHN long after the rash and blisters heal, because of nerve ...

The Varicella Zoster Virus (VZV) is a ubiquitous human alpha-herpesvirus that is the causative agent of chicken pox and shingles. Although an attenuated VZV vaccine (v-Oka) has been widely used in children in the United States, chicken pox outbreaks are still seen, and the shingles vaccine only reduces the risk of shingles by 50%. Therefore, VZV still remains an important public health concern....